Read More Pharma Industry News Amgen to acquire American biopharma company ChemoCentryx for $3.7bn Amgen has agreed to acquire ChemoCentryx, a biopharma company engaged in developing medications for inflammatory and autoimmune diseases… bySrinathAugust 4, 2022
